Guru P. Sonpavde, MD

Articles by Guru P. Sonpavde, MD

How should ctDNA guide adjuvant therapy after perioperative EV?

ByChandler Park, MD,Alexandra Drakaki, MD, PhD,Guru P. Sonpavde, MD

October 25th 2026

Neoadjuvant-only enfortumab vedotin in VOLGA may spare neuropathy, according to Alexandra Drakaki, MD, PhD; Guru P. Sonpavde, MD, urged caution.

Latest Updated Articles

Trending on Urology Times

Factors shaping PSMA-PET agent selection in prostate cancer

Nogapendekin alfa inbakicept plus BCG advances to final analysis in BCG-naïve NMIBC

Chad Ritch, MD, on using PSMA-PET to guide treatment decisions

Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026

Comparing PSMA-PET agents: What urologists should know